6D
6D81.F Dupont De Nemours Inc
- Market cap
- EUR 5.65B
- P/E
- 41.8x
- P/B
- 1.36x
- ROE
- 4.4%
- Dividend yield
- 1.64%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 6D81.F undervalued?
Graham number6D81.F trades 58.8% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Dupont De Nemours Inc fundamental analysis
No fundamental analysis for Dupont De Nemours Inc yet.
Dupont De Nemours Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Dupont De Nemours Inc
DuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. It operates through two segments, Healthcare & Water Technologies and Diversified Industrials. The company offers specialty components for medical devices, packaging and garments, and protective suits under the brand TYVEK; provides water filtration and separation solutions, including elements, modules, …
Full company profileDupont De Nemours Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Dupont De Nemours Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 48.2B | 62.5B | 86.0B | 21.5B | 20.4B | 16.7B | 13.0B | 6.61B | 6.72B | 6.85B | 7.00B |
| Gross Profit | 10.5B | 12.1B | 20.6B | 7.46B | 6.88B | 5.85B | 4.62B | 2.17B | 2.22B | 2.36B | 2.48B |
| Operating Income | 5.09B | 4.93B | 8.97B | 2.79B | 1.66B | 2.65B | 2.02B | 822M | 747M | 860M | 984M |
| EBITDA | - | 6.24B | 12.9B | 3.39B | 964M | 4.18B | 3.12B | - | - | - | - |
| Net Income | 4.32B | 1.46B | 3.84B | 498M | -2.95B | 6.47B | 5.80B | 423M | 703M | -779M | 608M |
| EPS | - | 1.88 | 5.08 | 0.67 | -4.02 | 13 | 13 | 0.98 | 1.68 | -5.71 | 4.50 |
| Balance Sheet | |||||||||||
| Total Assets | 79.5B | 192B | 188B | 69.4B | 70.9B | 45.7B | 41.4B | 38.6B | 36.6B | 21.6B | 21.1B |
| Total Liabilities | 52.3B | 90.2B | 91.9B | 27.8B | 31.8B | 18.7B | 14.5B | 13.8B | 12.8B | 7.47B | 7.18B |
| Shareholders' Equity | 26.0B | 100B | 94.6B | 41.0B | 38.5B | 26.4B | 26.5B | 24.3B | 23.4B | 13.9B | 13.8B |
| Cash & Short-term Investments | 6.61B | 13.4B | 13.5B | 1.54B | 2.54B | 2.01B | 3.66B | 2.39B | 1.85B | 715M | 1.74B |
| Cash Flow | |||||||||||
| Operating Cash Flow | -2.96B | -765M | 4.73B | 1.41B | 4.10B | 2.28B | 588M | 1.07B | 765M | 560M | 1.26B |
| Capital Expenditure | 4.10B | 3.88B | 4.00B | 2.65B | 1.26B | 3.24B | 743M | 2.48B | 605M | 388M | 356M |
| Free Cash Flow | - | 5.00B | 760M | -1.27B | 2.83B | -956M | -155M | -1.41B | 160M | 172M | 908M |
| Ratios | |||||||||||
| ROE | 16.6% | 1.5% | 4.1% | 1.2% | -7.7% | 24.5% | 21.9% | 1.7% | 3.0% | -5.6% | 4.4% |
| ROA | 5.4% | 0.8% | 2.0% | 0.7% | -4.2% | 14.1% | 14.0% | 1.1% | 1.9% | -3.6% | 2.9% |
| Net Profit Margin | 9.0% | 2.3% | 4.5% | 2.3% | -14.5% | 38.8% | 44.5% | 6.4% | 10.5% | -11.4% | 8.7% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Dupont De Nemours Inc dividends
- Dividend yield
- 1.64%
- Forward dividend
- 2.06 EUR
- Payout ratio
- -
- Ex-dividend date
- May 15, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 597M | 4.38 | - |
| 2024 | USD 635M | 1.52 | 90.3% |
| 2023 | USD 647M | 1.50 | 153.0% |
| 2022 | USD 652M | 1.42 | 11.2% |
| 2021 | USD 630M | 1.23 | 9.7% |
| 2020 | USD 882M | 1.20 | - |
| 2019 | EUR 1.61B | 2.18 | 323.5% |
| 2018 | EUR 3.49B | 4.62 | 90.8% |
| 2017 | EUR 3.39B | 4.37 | 232.5% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:3 on Jun 24, 2026.
Who owns Dupont De Nemours Inc
- Insiders 0.19%
- Institutions 80.87%
- Public & others 18.94%
- Shares outstanding 135M
- Free float 136M
Dupont De Nemours Inc company profile
- Company name
- Dupont De Nemours Inc
- Ticker
- 6D81.F
- Exchange
- Frankfurt Exchange
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 15,000
- Fiscal year end
- December
- Address
- Building 730, Wilmington, DE, United States, 19805
- Phone
- 302 295 5783
- Website
- dupont.com
About Dupont De Nemours Inc
DuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. It operates through two segments, Healthcare & Water Technologies and Diversified Industrials. The company offers specialty components for medical devices, packaging and garments, and protective suits under the brand TYVEK; provides water filtration and separation solutions, including elements, modules, and systems serving primarily industrial wastewater and energy markets, municipal and desalination applications, and life sciences and specialty sectors. It also offers AMBERLITE ion exchange resins, FILMTEC reverse osmosis and nanofiltration elements, and INGE and ITEGRATEC ultrafiltration modules. In addition, the company offers engineered products and integrated solutions for the non-residential, residential, and repair-and-remodel construction markets, includes TYVEK house wrap, STYROFOAM insulation, and CORIAN solid surface. Further, it engages in the design and production of engineered components, systems, and process solutions used in OEM and operational applications, such as automotive, aerospace, printing, and packaging. Additionally, the company offers Vespel shapes and parts, MOLYKOTE specialty lubricants, BETAFORCE and BETASEAL structural adhesives, and Cyrel flexographic printing plates. The company was formerly known as DowDuPont Inc. and changed its name to DuPont de Nemours, Inc. in June 2019. DuPont de Nemours, Inc. was incorporated in 2015 and is headquartered in Wilmington, Delaware.
Dupont De Nemours Inc management
10- Ms. Lori D. KochCEO & Director · born 1975
- Ms. Antonella B. FranzenSenior VP & CFO · born 1976
- Mr. Erik T. Hoover J.D.Senior VP & General Counsel · born 1974
- Mr. Christopher P. RaiaChief Human Resources Officer · born 1970
- Mr. Jeroen BloemhardPresident of Healthcare & Water Technologies · born 1969
- Mr. David KochChief Operations & Engineering Officer
- Ms. Madeleine G. BarberVP of Tax, Controller & Chief Accounting Officer · born 1964
- Mr. Marty DeGrootChief Technology Officer
- Mr. Matthew S. AbbottSVP, Chief Information Officer & Chief Procurement Officer · born 1977
- Ann GiancristoforoVP of Investor Relations, Corporate FP&A, Strategic Finance